Regulatory action marks the first engineered cell therapy approved for a solid tumor cancer in the United States.
FDA Grants Accelerated Approval to Adaptimmune Therapeutics’ Tecelra for Adults with Synovial Sarcoma Who Have Undergone Prior Chemotherapy
